Literature DB >> 9931074

Is gene therapy for hypertension possible?

M I Phillips.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9931074     DOI: 10.1161/01.hyp.33.1.8

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  6 in total

Review 1.  The impact of molecular medicine upon early cardiovascular drug development.

Authors:  M W Lunnon; M Braddock
Journal:  Br J Clin Pharmacol       Date:  2000-07       Impact factor: 4.335

Review 2.  Vectors for gene therapy of cardiovascular disease.

Authors:  J F Dedieu; A Mahfoudi; A Le Roux; D Branellec
Journal:  Curr Cardiol Rep       Date:  2000-01       Impact factor: 2.931

Review 3.  Gene therapy of hypertensive vascular injury.

Authors:  Y Chu; F M Faraci; D D Heistad
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

Review 4.  The potential role of antisense oligodeoxynucleotide therapy for cardiovascular disease.

Authors:  M I Phillips; S M Galli; J L Mehta
Journal:  Drugs       Date:  2000-08       Impact factor: 9.546

5.  Regulatable atrial natriuretic peptide gene therapy for hypertension.

Authors:  Kurt J Schillinger; Sophia Y Tsai; George E Taffet; Anilkumar K Reddy; Ali J Marian; Mark L Entman; Kazuhiro Oka; Lawrence Chan; Bert W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-14       Impact factor: 11.205

6.  Gene Therapy for Cardiovascular Disease.

Authors:  Kate L. Dishart; Lorraine M. Work; Laura Denby; Andrew H. Baker
Journal:  J Biomed Biotechnol       Date:  2003
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.